Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Wegovy (semaglutide): Also manufactured by Novo Nordisk, Wegovy contains the same active ingredient as Ozempic but at a higher dose and with FDA approval specifically for chronic weight management
Initial dose: 0.25 mg injected subcutaneously into the abdomen, thigh, or upper arm once weekly, with or without food
The injection reduces appetite
Potential short-term systemic effects may include: Facial flushing Warmth or vasodilatory sensation Lightheadedness Increased heart rate Temporary discomfort Why it matters: These effects are not just theoretical
US$ 28.78
US$ 20.67
US$ 22.44
US$ 24.27
US$ 28.67
US$ 28.35
US$ 28.59
